Insulet | PODD - 销售毛利



金融业
股票价格
USD
资产
USD 3.17B
现金及等价物
USD 534.9M
销售成本
USD 239.1M
流动资产
USD 1.85B
流动负债
USD 744.2M
债务
USD 948.4M
EBIT
USD 129.7M
EBITDA
USD 199.8M
员工
3.9K
EPS每股收益
USD 1.66
股本和储备
USD 1.42B
销售毛利
USD 562.6M
债务利息支出
USD 11M
利息收入
USD 4.9M
贷款资金
USD 929.5M
市值
USD 9.83B
净收入
USD 95M
营业费用
USD 672M
营业利润
USD 129.7M
普通股股本
USD 69.35M
PE价格收益
29.66
税前利润
USD 118.7M
销售收入
USD 801.7M
销售和管理费用
USD 344.8M
股票
USD 484.8M
贸易债权人
USD 123.3M
应收帐款人
USD 588.7M


销售毛利 更改 日
Abbott USD 6.65B 787M 2026-06
Align Technology USD 757.43M 20.84M 2026-06
AtriCure USD 109.31M 3.97M 2026-03
Baxter International USD 1.14B 251M 2026-06
Becton, Dickinson and Co. USD 2.32B 161M 2026-06
Boston Scientific USD 3.82B 210M 2026-06
Cardinal Health USD 2.56B 62M 2026-06
Cooper Companies USD 711.9M 23.5M 2026-06
Dexcom USD 750.3M 42.4M 2026-03
Edwards Lifesciences USD 1.35B 62.6M 2026-06
Eli Lilly USD 16.22B 301.7M 2026-03
Globus Medical USD 548.17M 51.91M 2026-06
ICU Medical USD 235.05M 28.83M 2026-06
Inogen USD 41.34M 1.39M 2024-09
Insulet USD 562.6M 21.8M 2026-06
Integra LifeSciences USD 215.97M 2.77M 2026-06
J&J USD 18.55B 1.31B 2026-06
Medtronic USD 6.36B 355M 2026-06
Merit Medical Systems USD 215.17M 30.37M 2026-06
Roche Holding CHF 22.69B 600M 2026-06
Solventum Corp USD 1.29B 189M 2026-06
Stryker USD 4.5B 688M 2026-06
Tandem Diabetes Care USD 144.78M 7.99M 2026-06
Teleflex USD 331.71M 24.28M 2026-06
West Pharmaceutical Services USD 296.4M 7.5M 2026-03
Zimmer Biomet Holdings USD 1.36B 149.4M 2026-06